These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18061869)

  • 21. Prophylactic HPV vaccines: new interventions for cancer control.
    Barr E; Sings HL
    Vaccine; 2008 Nov; 26(49):6244-57. PubMed ID: 18694795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing patient risk for human papillomavirus infection and cervical cancer.
    Herbert J; Coffin J
    J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus and lower genital neoplasia in renal transplant patients.
    Halpert R; Fruchter RG; Sedlis A; Butt K; Boyce JG; Sillman FH
    Obstet Gynecol; 1986 Aug; 68(2):251-8. PubMed ID: 3016625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of human papillomavirus with vulvar and vaginal intraepithelial disease: opportunities for prevention.
    Pearson JM; Feltman RS; Twiggs LB
    Womens Health (Lond); 2008 Mar; 4(2):143-50. PubMed ID: 19072516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors.
    Xu L; Selk A; Garland SM; Bogliatto F; Kyrgiou M; Weyers S; Arbyn M
    Expert Rev Vaccines; 2019 Nov; 18(11):1157-1166. PubMed ID: 31718338
    [No Abstract]   [Full Text] [Related]  

  • 26. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Few More Reasons to Vaccinate Against Human Papillomavirus: The Vulva and Vagina.
    Feldman S
    Obstet Gynecol; 2018 Aug; 132(2):259-260. PubMed ID: 29995721
    [No Abstract]   [Full Text] [Related]  

  • 28. Vulvar and vaginal cancers as seen at the University College Hospital Ibadan, Nigeria.
    Babarinsa LA; Fakokunde FA; Ogunbiyi JO; Adewole IF
    Afr J Med Med Sci; 1999; 28(1-2):77-80. PubMed ID: 12953992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Three cases of vaginal adenosis after topical 5-fluorouracil therapy for vaginal HPV-associated lesions].
    Georgiev D; Karag'ozov I; Velev M; Makaveeva V
    Akush Ginekol (Sofiia); 2006; 45(3):59-61. PubMed ID: 16889191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.
    Kahn JA; Ding L; Huang B; Zimet GD; Rosenthal SL; Frazier AL
    Pediatrics; 2009 Jun; 123(6):1439-45. PubMed ID: 19482752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment on the Article: Srodon M, Stoler MH, Baber GB, et al. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN) Am J Surg Pathol. 2006;30:1513-1518.
    Sideri M; Jones RW; Heller DS; Haefner H; Neill S; Preti M; Scurry J; Wilkinson EJ; Edwards L
    Am J Surg Pathol; 2007 Sep; 31(9):1452; author reply 1452--4. PubMed ID: 17721204
    [No Abstract]   [Full Text] [Related]  

  • 40. Vulvar intraepithelial neoplasia.
    Caglar H; Tamer S; Hreshchyshyn MM
    Obstet Gynecol; 1982 Sep; 60(3):346-9. PubMed ID: 7121915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.